Literature DB >> 10648899

Cellular distribution of the splice variants of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC(1)-R) in the rat brain by in situ RT-PCR.

C J Zhou1, S Kikuyama, M Shibanuma, T Hirabayashi, S Nakajo, A Arimura, S Shioda.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a pleiotropic neuropeptide and its specific receptor (the PAC(1) receptor) is widely distributed in the rat brain. It has been reported that alternative splicing of the region encoding the third intracellular loop of the PAC(1) receptor generates six isoforms which are differentially coupled to signal transduction pathways, but the precise distribution and localization of these splice isoforms in the brain remain to be determined. Using the initial specific primer pairs which correspond to the 'hip' or 'hop' types of receptors for the solution-phase reverse transcription-polymerase chain reaction (RT-PCR), we demonstrated that the major splice variants of the PAC(1) receptor in various regions of the rat brain are the short splice isoform 'PAC(1)-R-s' which does not contain either the 'hip' or 'hop' cassette and the another splice isoform, 'PAC(1)-R-hop', which contains the 'hop' cassette. With an innovative molecular histochemical technique, in situ RT-PCR, we determined that these two splice isoforms are both intensely expressed in the mitral cells of the olfactory bulb, the Purkinje cells of the cerebellum, the pyramidal cells of the hippocampus and neocortex, and many neurons in the nuclei of hypothalamus and thalamus as well as other regions. The initial mapping of the cell type-specific expression of these two splice variants of the PAC(1) receptor provides the basis for a better understanding of the functional significance of the PAC(1)-R and its ligand PACAP in various brain regions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648899     DOI: 10.1016/s0169-328x(99)00300-9

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  13 in total

1.  Granule cell survival is deficient in PAC1-/- mutant cerebellum.

Authors:  Anthony Falluel-Morel; Liana I Tascau; Katie Sokolowski; Philippe Brabet; Emanuel DiCicco-Bloom
Journal:  J Mol Neurosci       Date:  2008-04-12       Impact factor: 3.444

Review 2.  Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse?

Authors:  Corey B Smith; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-05-18       Impact factor: 3.444

Review 3.  Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine.

Authors:  Anne Luise Haulund Vollesen; Faisal Mohammad Amin; Messoud Ashina
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

4.  Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene.

Authors:  Anika Agarwal; Lisa M Halvorson; Gabor Legradi
Journal:  Brain Res Mol Brain Res       Date:  2005-07-29

5.  PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cells.

Authors:  Yvonne Holighaus; Tomris Mustafa; Lee E Eiden
Journal:  Peptides       Date:  2011-06-12       Impact factor: 3.750

6.  C-terminal amidation of PACAP-38 and PACAP-27 is dispensable for biological activity at the PAC1 receptor.

Authors:  Andrew C Emery; Ryan A Alvarez; Philip Abboud; Wenqin Xu; Craig D Westover; Maribeth V Eiden; Lee E Eiden
Journal:  Peptides       Date:  2016-03-11       Impact factor: 3.750

7.  Impaired expression of an organic cation transporter, IMPT1, in a knockout mouse model for kidney stone disease.

Authors:  Eleni G Tzortzaki; Min Yang; Dayna Glass; Li Deng; Andrew P Evan; Sharon B Bledsoe; Peter J Stambrook; Amrik Sahota; Jay A Tischfield
Journal:  Urol Res       Date:  2003-07-11

8.  PACAP causes PAC1/VPAC2 receptor mediated hypertension and sympathoexcitation in normal and hypertensive rats.

Authors:  M M J Farnham; M S Y Lung; V J Tallapragada; P M Pilowsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

Review 9.  Interactions of PACAP and ceramides in the control of granule cell apoptosis during cerebellar development.

Authors:  A Falluel-Morel; N Aubert; D Vaudry; A Desfeux; A Allais; D Burel; M Basille; H Vaudry; V Laudenbach; B J Gonzalez
Journal:  J Mol Neurosci       Date:  2008-06-24       Impact factor: 3.444

10.  Pituitary adenylate cyclase-activating polypeptide-induced PAC1 receptor internalization and recruitment of MEK/ERK signaling enhance excitability of dentate gyrus granule cells.

Authors:  Gregory C Johnson; Rodney L Parsons; Victor May; Sayamwong E Hammack
Journal:  Am J Physiol Cell Physiol       Date:  2020-03-18       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.